Literature DB >> 24081468

Screening of monoclonal antibody formulations based on high-throughput thermostability and viscosity measurements: design of experiment and statistical analysis.

Feng He1, Christopher E Woods, Egor Trilisky, Keith M Bower, Jennifer R Litowski, Bruce A Kerwin, Gerald W Becker, Linda O Narhi, Vladimir I Razinkov.   

Abstract

The purpose of this study was to demonstrate the utility of combining a design of experiment (DOE) approach with high-throughput formulation screening to identify the main factors affecting protein thermostability and solution viscosity. The optimization of buffer compositions was guided by statistical analysis of the data to obtain the targeted combination of low viscosity and high thermostability. Different monoclonal antibody (mAb) formulation variables were evaluated in the study to achieve optimization of two parameters: (i) thermostability characterized by temperature of hydrophobic exposure and (ii) viscosity. High-throughput measurements were employed to characterize both parameters. The significance of each factor and the two-way interactions between them was studied by multivariable regression analysis. An experimental design was used to estimate the significance of all factors, including interaction effects. The range of optimal buffer compositions that maximized thermostability and minimized viscosity of a mAb formulation was determined. The described high-throughput methods are well suited for characterization of multiple protein formulation compositions with minimized resources such as time and material. The DOE approach can be successfully applied to the screening of mAb formulations early in the development lifecycle.
Copyright © 2010 Wiley-Liss, Inc.

Keywords:  Design of experiment; Excipients; High throughput; Monoclonal antibodies; Preformulation; Protein formulation; Thermal analysis; Viscosity

Mesh:

Substances:

Year:  2010        PMID: 24081468     DOI: 10.1002/jps.22384

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

1.  Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of Size, Electroviscous Effect and Protein-Protein Interactions.

Authors:  Ashlesha S Raut; Devendra S Kalonia
Journal:  Pharm Res       Date:  2015-08-19       Impact factor: 4.200

2.  Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties.

Authors:  Li Li; Sandeep Kumar; Patrick M Buck; Christopher Burns; Janelle Lavoie; Satish K Singh; Nicholas W Warne; Pilarin Nichols; Nicholas Luksha; Davin Boardman
Journal:  Pharm Res       Date:  2014-06-07       Impact factor: 4.200

3.  Parallel temperature-dependent microrheological measurements in a microfluidic chip.

Authors:  Lilian Lam Josephson; William J Galush; Eric M Furst
Journal:  Biomicrofluidics       Date:  2016-06-14       Impact factor: 2.800

4.  An effective thiol-reactive probe for differential scanning fluorimetry with a standard real-time polymerase chain reaction device.

Authors:  Lukas Hofmann; Sahil Gulati; Avery Sears; Phoebe L Stewart; Krzysztof Palczewski
Journal:  Anal Biochem       Date:  2016-02-04       Impact factor: 3.365

5.  Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody.

Authors:  Sanjaya Singh; Rachel R Kroe-Barrett; Keith A Canada; Xiang Zhu; Eliud Sepulveda; Helen Wu; Yaqin He; Ernest L Raymond; Jennifer Ahlberg; Lee E Frego; Laura M Amodeo; Katrina M Catron; David H Presky; Jeffrey H Hanke
Journal:  MAbs       Date:  2015-04-23       Impact factor: 5.857

6.  Automated Gravimetric Calibration to Optimize the Accuracy and Precision of TECAN Freedom EVO Liquid Handler.

Authors:  Laurent Bessemans; Vanessa Jully; Caroline de Raikem; Mathieu Albanese; Nicolas Moniotte; Pascal Silversmet; Dominique Lemoine
Journal:  J Lab Autom       Date:  2016-02-23

7.  Characterization of highly concentrated antibody solution - A toolbox for the description of protein long-term solution stability.

Authors:  Marie-Therese Schermeyer; Anna K Wöll; Bas Kokke; Michel Eppink; Jürgen Hubbuch
Journal:  MAbs       Date:  2017-06-15       Impact factor: 5.857

8.  Multi-criteria manufacturability indices for ranking high-concentration monoclonal antibody formulations.

Authors:  Yang Yang; Ajoy Velayudhan; Nina F Thornhill; Suzanne S Farid
Journal:  Biotechnol Bioeng       Date:  2017-05-26       Impact factor: 4.530

9.  Predicting Antibody Developability Profiles Through Early Stage Discovery Screening.

Authors:  Marc Bailly; Carl Mieczkowski; Veronica Juan; Essam Metwally; Daniela Tomazela; Jeanne Baker; Makiko Uchida; Ester Kofman; Fahimeh Raoufi; Soha Motlagh; Yao Yu; Jihea Park; Smita Raghava; John Welsh; Michael Rauscher; Gopalan Raghunathan; Mark Hsieh; Yi-Ling Chen; Hang Thu Nguyen; Nhung Nguyen; Dan Cipriano; Laurence Fayadat-Dilman
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

10.  Stability of a high-concentration monoclonal antibody solution produced by liquid-liquid phase separation.

Authors:  Jack E Bramham; Stephanie A Davies; Adrian Podmore; Alexander P Golovanov
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.